CD80/86 molecules on activated antigen presenting cells (APCs). Once mobilized, T cells also express other receptors that inhibit their proliferation and cytokine production, known as immune checkpoints. Among these…
this disease. In recent years, researchers have begun to investigate the expression of immunomodulatory checkpoint molecules in drug-resistant neuroblastoma cells as a potential target for new therapies
These molecules include antigen presenting molecules, adhesion molecules, co-stimulatory molecules, and inhibitors or checkpoint molecules, etc. The spatial and temporal changes of these molecules determine the…
negative immune-regulatory molecules in tumor microenvironment. PD-L1 has been identified as negative checkpoint molecules that promote immune evasion of tumor cells. The interaction
ideal target for cancer immunotherapy. Our recent findings of Globo H ceramide as immune checkpoint molecules and angiogenic factors provide further impetus for Globo H-targeted immunotherapy. These studies thus
shown to deplete pro-tumor macrophages in the tumor microenvironment. Nivolumab inhibits the immune checkpoint molecule, PD-1, which restores anti-tumor activity in tumorinfiltrating T cells. Purpose: To assess
novo psoriasis. Programmed cell death protein 1 (PD-1) is an immune checkpoint molecule. Immune checkpoint inhibitors like Nivolumab block the interaction between PD-1 and PD ligand-1, stimulating
cells to evade the immune system, including alterations in antigen presentation, downregulation of immune checkpoint molecules, and recruitment of immunosuppressive cells. The article will also discuss the current…
known about the intrinsic mechanisms in effector T cells to regulate the balance of checkpoint molecules in response to different stimuli. Transcription factors early growth response gene
Purpose: Antibodies that target immune checkpoint molecules have demonstrated significant and durable clinical benefit through re-activation and proliferation of pre-existing tumor-infiltrating CD8+ T cells in a broad…
administration of antibodies blocking the immune checkpoint molecules programmed cell death protein 1 (PD-1) or programmed cell death 1 ligand 1 (PD-L1) has evolved as one of major ... antibodies for the treatment of…
lymphocytes are eliminated or rendered anergic. Peripheral tolerance mechanisms, including regulatory T cells (Tregs), checkpoint molecules, and the role of the microbiome, ensure that self-reactive cells are controlled
molecular pathways involved in tolerance, highlighting the role of regulatory T cells, immune checkpoint molecules, and the role of antigen-presenting cells in modulating the immune response. Moreover, the development
cell homeostasis. Reduced immunogenicity and uncontrolled tumour growth are caused by overexpression of inhibitory checkpoint molecules during the evolution of tumours. PD-L1 positive tumours in clinical and preclinical…
clinical trials led to date to disappointing results. The immunotherapeutic intervention targeting T-cell checkpoint molecules has been proposed as well, but results obtained indicate that ACC patients would
diseases. A recent study by our group demonstrated the function of EGR2 as a checkpoint molecule controlling the proliferation and differentiation of the T cells, confirming its regulatory role, which
antigen specific CD4+ T cells. Lastly, when combined with the genetic deficiency of another checkpoint molecule, synergistic or additive immune activation was observed
development of targeted immunomodulatory agents such as cytokine inhibitors, immune checkpoint regulators, and small-molecule modulators. These innovations have revolutionized therapeutic approaches, improving patient…
analysis of the pharmacokinetic interactions associated with contemporary anticancer therapies, including small molecules, monoclonal antibodies, and immune checkpoint inhibitors. We examine how these interactions can…
recent hot topic among scientists over the world. So far, the discovered checkpoint protein molecules include cytotoxic T lymphocyte antigen-4 (CTLA-4), programmed death-1 (PD-1), lymphocyte activation
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.